Graypoint LLC Increases Stake in HCA Healthcare, Inc. (NYSE:HCA)

Graypoint LLC raised its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 1,840 shares of the company’s stock after purchasing an additional 51 shares during the period. Graypoint LLC’s holdings in HCA Healthcare were worth $748,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in HCA. Terra Nova Asset Management LLC increased its stake in shares of HCA Healthcare by 0.3% in the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after purchasing an additional 26 shares in the last quarter. Massmutual Trust Co. FSB ADV lifted its position in shares of HCA Healthcare by 7.4% in the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after acquiring an additional 29 shares in the last quarter. Waldron Private Wealth LLC lifted its holdings in HCA Healthcare by 1.8% in the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after purchasing an additional 29 shares in the last quarter. Brookstone Capital Management raised its position in shares of HCA Healthcare by 0.7% during the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after buying an additional 30 shares during the last quarter. Finally, UMB Bank n.a. boosted its position in shares of HCA Healthcare by 2.4% during the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after acquiring an additional 30 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

HCA has been the subject of several research reports. Leerink Partners increased their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Barclays lifted their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 24th. KeyCorp cut their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Royal Bank of Canada boosted their price objective on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Finally, Oppenheimer upped their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a report on Monday, October 28th. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $379.39.

Insider Activity

In related news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.70% of the company’s stock.

HCA Healthcare Stock Up 2.1 %

HCA stock opened at $356.03 on Friday. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The stock has a market capitalization of $90.18 billion, a P/E ratio of 15.99, a PEG ratio of 1.39 and a beta of 1.68. The company has a 50 day moving average price of $391.18 and a two-hundred day moving average price of $355.72. HCA Healthcare, Inc. has a one year low of $226.48 and a one year high of $417.14.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.74%. HCA Healthcare’s payout ratio is 11.85%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.